The Patent Finder

Oncimmune Germany GmbH

Also on record
Records under this name other than the patents Oncimmune Germany GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 4 of 4 · Back to Oncimmune Germany GmbH

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,036,746Method for the Diagnosis of Neuromyelitis Optica
Lapsed on the fee record
Ended Jul 31, 2026 · High confidence
Lapsed on the fee recordEnded Jul 31, 2026High confidence
US 9,588,115Method for the Diagnosis of Neuromyelitis Optica
Lapsed on the fee record
Ended Mar 7, 2025 · High confidence
Lapsed on the fee recordEnded Mar 7, 2025High confidence
US 10,746,735Marker sequences for diagnosing and stratifying SLE patients
Lapsed on the fee record
Ended Aug 18, 2024 · USPTO record
Lapsed on the fee recordEnded Aug 18, 2024USPTO record
US 10,060,911Method for diagnosis of high-affinity binders and marker sequences
Lapsed on the fee record
Ended Aug 28, 2022 · USPTO record
Lapsed on the fee recordEnded Aug 28, 2022USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited